{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:02Z","timestamp":1761468902571,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.transci.2020.102861","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:59:01Z","timestamp":1593431941000},"page":"102861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spotlight on the current perspectives on applications of human blood cell culture and organoids: Introductory remarks"],"prefix":"10.1016","volume":"59","author":[{"given":"Jerard","family":"Seghatchian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Amiral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Febuary(1)","key":"10.1016\/j.transci.2020.102861_bib0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.transci.2018.12.015","article-title":"Ex vivo generation of transfusable red blood cells from various stem cell sources: a concise revisit of where we are now","volume":"58","author":"Christaki","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2020.102861_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5661\/bger-25-187","article-title":"In vitro production of transfusable red blood cells","volume":"25","author":"Nakamura","year":"2008","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"1\u20132","key":"10.1016\/j.transci.2020.102861_bib0015","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ddmec.2011.10.002","article-title":"Blood in a dish: in vitro synthesis of red blood cells","volume":"8","author":"Migliaccio","year":"2011","journal-title":"Drug Discov Today Dis Mech"},{"issue":"February (1)","key":"10.1016\/j.transci.2020.102861_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-020-01603-z","article-title":"Transforming growth factor \u03b21 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy","volume":"19","author":"Kuhikar","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"November 5","key":"10.1016\/j.transci.2020.102861_bib0025","first-page":"1626","article-title":"Optimization of an erythroid culture system to reduce the cost of in vitro production of red blood cells","volume":"30","author":"Poldee","year":"2018","journal-title":"Methods X."},{"issue":"May(5)","key":"10.1016\/j.transci.2020.102861_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.exphem.2014.02.002","article-title":"Biomanufacture of human platelets for transfusion: rationale and approaches","volume":"42","author":"Lee","year":"2014","journal-title":"Exp Hematol"},{"issue":"July 2019","key":"10.1016\/j.transci.2020.102861_bib0035","first-page":"92813","article-title":"Current advances in red blood cell generation using stem cells from diverse sources","volume":"29","author":"Seo","year":"2019","journal-title":"Stem Cells Int"},{"issue":"March(2)","key":"10.1016\/j.transci.2020.102861_bib0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3349\/ymj.2014.55.2.304","article-title":"In-vitro stem cell derived red blood cells for transfusion: are we there yet?","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"issue":"August (9)","key":"10.1016\/j.transci.2020.102861_bib0045","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2009-03-209205","article-title":"Exposure of human megakaryocytes to high shear rates accelerates platelet production","volume":"27","author":"Dunois-Lard\u00e9","year":"2009","journal-title":"Blood"},{"issue":"June (1)","key":"10.1016\/j.transci.2020.102861_bib0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/s40064-016-2384-1","article-title":"Platelet generation in vivo and in vitro","volume":"21","author":"Wang","year":"2016","journal-title":"Springerplus"},{"issue":"September(9)","key":"10.1016\/j.transci.2020.102861_bib0055","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/jth.13736","article-title":"Platelet production from induced pluripotent stem cells","volume":"15","author":"Sugimoto","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"May(4)","key":"10.1016\/j.transci.2020.102861_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/vox.12776","article-title":"A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device","volume":"114","author":"Six","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2020.102861_bib0065","series-title":"Leukocyte Culture., encyclopedia of immunology (Second edition)","first-page":"1569","author":"Cesano","year":"1998"},{"issue":"May 2","key":"10.1016\/j.transci.2020.102861_bib0070","first-page":"1","article-title":"Blood cells and leukocyte culture \u2013 a short review","volume":"1","author":"Fathima","year":"2017","journal-title":"Blood Res Transfus J."},{"issue":"March (1)","key":"10.1016\/j.transci.2020.102861_bib0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40425-019-0553-9","article-title":"Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment","volume":"14","author":"Courau","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"September (6)","key":"10.1016\/j.transci.2020.102861_bib0080","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"6","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"1 January","key":"10.1016\/j.transci.2020.102861_bib0085","article-title":"Organoids: A brief overview of stem cell-derived organoids: how they are made and what the challenges are","volume":"15","author":"de Sousa","year":"2018","journal-title":"Nat Methods"},{"key":"10.1016\/j.transci.2020.102861_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.ctdb.2016.01.009","article-title":"Hematopoietic stem cell and its bone marrow niche","volume":"118","author":"Yu","year":"2016","journal-title":"Curr Top Dev Biol"},{"issue":"4","key":"10.1016\/j.transci.2020.102861_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000366319","article-title":"Survival and senescence of human young red cells in vitro","volume":"34","author":"Risso","year":"2014","journal-title":"Cell Physiol Biochem"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022030166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022030166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:13Z","timestamp":1761468673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022030166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S147305022030166X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102861","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spotlight on the current perspectives on applications of human blood cell culture and organoids: Introductory remarks","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102861"}}